LPL Receptor Inhibitors

查看全部
Product Name LPAR1 LPAR2 LPAR3 LPAR5 S1PR1 S1PR2 S1PR3 S1PR4 S1PR5 Purity
(R)-FTY 720P
(R)-SLB1122168 free base
(R)-VPC44116
(S)-FTY-720 Vinylphosphonate
(S)-FTY720-phosphonate 99.91%
(S)-PF-462991
1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA
1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium
1-Hexadecyl lysophosphatidic acid sodium
1-Octadecyl lysophosphatidic acid 95%
1-Oleoyl lysophosphatidic acid 99.90%
1-Oleoyl lysophosphatidic acid sodium
1-Oleoyl lysophosphatidic acid sodium 99.96%
2-Acetyl-4-tetrahydroxybutyl imidazole 98.06%
2-Acetyl-4-tetrahydroxybutyl imidazole-13C6
2ccPA sodium
A-971432 99.31%
A6770 98.23%
AB1
ACT-1016-0707 98.28%
ACT-209905
AM095 99.72%
AM095 free acid 99.02%
AM966 99.86%
AMG 369
Amiselimod
Amiselimod hydrochloride 98.86%
Anti-LPA/Lysophosphatidic acid Antibody (504B3)
AS2717638 99.85%
ASP-4058 99.54%
ASP-4058 hydrochloride 99.71%
ASP1126
ASP6432 99.92%
ATX inhibitor 27
Autotaxin-IN-6 99.88%
Autotaxin-IN-8
AUY 954 hydrochloride
AUY954
AzoLPA ammonium
BMS-520
BMS-960
BMS-960 free base
BMS-986020 99.91%
BMS-986020 sodium 99.88%
BMS-986104
BMS-986104 hydrochloride
BMS-986278 99.93%
BMT-136088
BrP-LPA
BrP-LPA sodium
C16-Sphingosine-1-phosphate 99.9%
CAY10444 98.0%
CAY10734
Cenerimod 99.43%
Ceralifimod 99.29%
Ceranib-2 98.92%
CRT0273750 98.81%
CS-0777
CS-0777-P
CS-2100 99.12%
CS1P1
Cudetaxestat 98.32%
CYM-5478 99.44%
CYM-5482 98.29%
CYM-5520 98.61%
CYM-5541 99.98%
CYM50179 96.06%
CYM50260 98.94%
CYM50308 98.0%
CYM50358 98.33%
CYM50358 hydrochloride
CYM50374
CYM5181
CYM5442 98.83%
CYM5442 hydrochloride
Decyl phosphate
Etrasimod 99.91%
Etrasimod arginine 99.86%
Etrasimod-d9
Ex26 99%
Fingolimod phosphate 99.18%
Fingolimod phosphate-d4
FTY720 (S)-Phosphate 99.57%
Ginkgolic acid 2-phosphate
GLPG2938 99.94%
Glycocholic acid 99.90%
Glycocholic acid hydrate 99.85%
Glycocholic acid sodium 97.0%
Glycocholic acid-13C2,d4N
Glycocholic acid-d4 99.92%
GRI977143 99.29%
GS-2278 98.70%
GSK 1842799 TFA
GSK-2262167 sodium
GSK1842799
GSK2018682 98.02%
GSK2018682 hydrochloride
GSK2263167
GSK3178022
H2L 5765834 98.66%
H2L5186303 98.50%
H2L5186303 (Standard)
HL001 98.90%
Icanbelimod 99.90%
IMMH001 98.10%
JTE-013 99.57%
Ki16198 98.17%
Ki16425 99.14%
KRO-105714
KRP-203 monophosphate
KSI-6666 96.15%
L-NASPA
L-NASPA ammonium
L-threo Lysosphingomyelin (d18:1) 98.0%
Lp(a)-IN-8
LPA receptor antagonist-1
LPA1 receptor antagonist 1 99.13%
LPA1 receptor antagonist-7
LPA2 antagonist 1 98.63%
LPA2 antagonist 2 95.0%
LPA2 antagonist 5
LPA2 antagonist 6
LPA5 antagonist 2 99.62%
LPA5 antagonist 3
LPAR1 antagonist 1 98.85%
LPAR1 antagonist 2
Lpathomab
LX2931 98.88%
LX2932
MK-571 98.85%
MK-571 sodium 99.75%
Mocravimod 98.39%
Mocravimod hydrochloride 99.99%
Myristoyl pentapeptide-17 acetate
N-PTyrosine PA ammonium
NAEPA 98.06%
NIBR0213 98.91%
NSC12404
Obicetrapib 99.93%
Obicetrapib potassium
Obicetrapib sodium
ONO-0300302 98.02%
ONO-0740556 99.78%
ONO-7300243 98.11%
ONO-9780307 99.94%
ONO-9910539
Ozanimod hydrochloride 98.10%
Palmitoyl 3-carbacyclic phosphatidic acid 99.9%
PF-462991
PF-543 99.85%
PF-543 Citrate 99.47%
PF-543 hydrochloride
Ponesimod 99.78%
Ponesimod-d4
pro-FTY
Radioprotectin-1 99.49%
RBM10-8
RP-001
RP-001 hydrochloride 98.8%
RP-1859
RP101075 99.19%
RP101442
RP101988 98.80%
S1p receptor agonist 2
S1P1 agonist 1 99.92%
S1P1 agonist 4
S1P1 agonist 5
S1P1 agonist 6
S1P1 agonist 7
S1P1 agonist III 99.64%
S1P2 antagonist 1
S1P5 receptor agonist-1
S1P5 receptor antagonist 1
S1PL-IN- 2
S1PL-IN-1 99.9%
S1PR1 agonist 1
S1PR1 agonist 2
S1PR1 agonist 3
S1PR1 Human Pre-designed siRNA Set A
S1PR1 ligand 1
S1PR1 modulator 1 99.52%
S1pr1 Mouse Pre-designed siRNA Set A
S1pr1 Rat Pre-designed siRNA Set A
S1PR1-MO-1
S1PR1/S1PR5 agonist-1
S1PR2 Human Pre-designed siRNA Set A
S1pr2 Mouse Pre-designed siRNA Set A
S1pr2 Rat Pre-designed siRNA Set A
S1PR3 Human Pre-designed siRNA Set A
S1pr3 Mouse Pre-designed siRNA Set A
S1PR4 Human Pre-designed siRNA Set A
S1pr4 Mouse Pre-designed siRNA Set A
S1PR5 Human Pre-designed siRNA Set A
S1pr5 Mouse Pre-designed siRNA Set A
S1pr5 Rat Pre-designed siRNA Set A
S1PR5-IN-1 99.58%
SACLAC 99.70%
SAR247799 99.38%
SEW​2871 99.88%
Siponimod hemifumarate 99.64%
Siponimod-d11
SLB1122168
SLB1122168 formic 99.91%
SLB1122168 free base
SLF1081851 98.02%
SLF1081851 hydrochloride
SLF1081851 TFA
SLF80821178 99.70%
SLF80821178 hydrochloride
Sonepcizumab 95.00%
Sphingomab 97.91%
SPL-IN-1
Spns2-IN-1
Spns2-IN-2
Spns2-IN-3
Sumonerimod hemicalcium
TAK-615 98.07%
Tamuzimod
TASP0277308
TC LPA5 4 99.69%
TC LPA5 4 (Standard)
TC-SP 14
TRV045 98.15%
TY-52156 99.25%
TYY-31
UCM-05194 ammonium
Udifitimod
Vibozilimod 99.52%
VPC 01091
VPC 23019 99.20%
VPC 23153
VPC12249
W123
W140 hydrobromide
W146 99.83%
W146 TFA 98.22%
XAX-162
XL541
Zectivimod 99.35%
Sodium glycocholate hydrate, 98% 99.91%
High density lipoprotein (human)
Ozanimod 99.98%
Ozanimod-d6
Poloxamer 407 (F127)
Glycocholic acid-d5 99.9%
Fingolimod hydrochloride 99.94%
Myristoyl pentapeptide-17
Fingolimod-d4 99.11%
Fingolimod-d4 hydrochloride 99.0%
Fingolimod 99.97%
Siponimod 99.95%
Sphingosine-1-phosphate-d7 99.9%
Sphingosine-1-phosphate 99.94%

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础